Three Medical Centers Cancel CBP, ICE Contracts
The three universities cancelled their contracts with US Customs and Border Protection or US Immigration and Customs Enforcement after public pressure.
Related Articles
Blood Eosinophil Counts Might be Predictor for Childhood Asthma and Treatment Response
A deep-dive analysis of preschoolers’ lungs can help pediatricians identify potential cases of asthma and responsiveness to corticosteroids.
Can Antihistamines Trigger Seizures in Young Kids?
First-generation antihistamines were associated with an increased risk for seizures in children aged 6-24 months.
The Link Between Vision Impairment and Dementia in Older Adults
A new study found vision impairment may be to blame for nearly one in five cases of dementia.
Long-Term Outcomes in Kidney Transplant: The Need to Challenge the Status Quo
An expert panel reviews long-term outcomes of kidney transplantation and the importance of understanding the patient experience.
CGM Sweet Talk w/ the Sugar Queens: Using CGM Data for Lifestyle Changes
Join the Sugar Queens in this live 30-minute certified event, where they will demonstrate how continuous glucose monitoring (CGM) can be used to help persons…
Autism Spectrum Disorder, Adults: Diagnosis and Management
Covering identification, assessment, and interventions for adults with suspected or confirmed autism spectrum disorder
Minorities Remain Underrepresented in ICI Cancer Trials
Hispanic/Latinx and Black patients are underrepresented in immune checkpoint inhibitor clinical trials, but recent years have seen some improvement in their inclusion.
Community Considerations: The Ins and Outs of Immunotherapy for the Treatment of Cancer
Do you know every organ system that immune-related adverse effects can affect?
Not Kidding: Yellow Dye 5 May Be the Key to Invisibility
A common food dye turned mice see-through, a “stunning” finding that could revolutionize imaging techniques in medicine.
Pathologist and Oncologist Collaboration for Enhanced EGFR-Mutated NSCLC Care
Did you know that activating EGFR mutations demonstrate differential sensitivity to EGFR-directed targeted therapies?